Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?
MA Gómez-Aparicio, F López-Campos, D Buchser… - Cancers, 2024 - mdpi.com
Simple Summary First-line treatment options for patients with hormone-sensitive metastatic
prostate cancer (mHSPC) have evolved in recent years with treatment intensification …
prostate cancer (mHSPC) have evolved in recent years with treatment intensification …
[HTML][HTML] Survival Patterns Based on First-site–specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?
ME Ahmed, AM Mahmoud, G Reitano, W Zeina… - European Urology Open …, 2024 - Elsevier
Background and objective Visceral metastatic disease in prostate cancer patients conveys a
poor prognosis. Using advanced imaging techniques, studies have demonstrated increasing …
poor prognosis. Using advanced imaging techniques, studies have demonstrated increasing …
Survival of metastatic urothelial carcinoma of urinary bladder according to number and location of visceral metastases
F Di Bello, M de Angelis, C Siech, LMI Jannello… - Clinical Genitourinary …, 2024 - Elsevier
Objective To test the association between number as well as locations of organ-specific
metastatic sites and overall survival (OS) in systhemic-therapy exposed metastatic urothelial …
metastatic sites and overall survival (OS) in systhemic-therapy exposed metastatic urothelial …
Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: Patient Selection and Overview of Doublet and Triplet Therapy Data
JW Shevach, JJ Park… - Advances in …, 2024 - advances-oncology.com
For decades, the treatment of men with metastatic hormone-sensitive prostate cancer
(mHSPC) was endocrine monotherapy with androgen deprivation therapy (ADT)[1] …
(mHSPC) was endocrine monotherapy with androgen deprivation therapy (ADT)[1] …
[引用][C] Prostate Cancer Survival Differs by Site of Visceral Metastases.
N Persaud - Cancer Therapy Advisor, 2023 - go.gale.com
In patients with metastatic prostate cancer, those with lung-only visceral metastases have
better overall survival (OS) than those with liver-only or brain-only visceral metastases …
better overall survival (OS) than those with liver-only or brain-only visceral metastases …